ANTI-cMET-ANTIKÖRPER

European patent · EP2370468 · In force

Register entry

Publication number
EP2370468
Application number
EP09771324
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 2, 2009
Published
Oct 5, 2011
Granted
Apr 5, 2017
Protection ends at the latest
Dec 1, 2029
Next annual fee due
Dec 31, 2026
IPC classes
C07K 16/28 (2006.01)
C07K 16/00 (2006.01)
C07K 16/46 (2006.01)
A61K 39/395 (2006.01)
A61P 35/00 (2006.01)
Priority
WO PCT/IB2008/055663 02.12.2008
US 184502 P 05.06.2009
PCT application
PCT/EP2009/066201 02.12.2009
PCT publication
WO2010/069765 24.06.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  5. Jul 6, 2017

    Agent entered

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 06.07.2017

  6. Apr 5, 2017

    Granted

    Published in Swissreg on 05.04.2017

Parties

Holder

Pierre Fabre Médicament

92100 Boulogne-Billancourt, FR

Inventor

GOETSCH, Liliane

F-74130 Ayze, FR

WURCH, Thierry

F-74140 Machilly, FR

BES, Cédric

F-30250 Villevieille, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.